In a filing, ARS Pharmaceuticals Inc revealed its Chief Operating Officer Dorsey Brian unloaded Company’s shares for reported $0.39 million on Aug 13 ’24. In the deal valued at $13.00 per share,30,000 shares were sold. As a result of this transaction, Dorsey Brian now holds 6,024 shares worth roughly $80299.92.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Tanimoto Sarina sold 100,000 shares, generating $1,247,555 in total proceeds. Upon selling the shares at $12.48, the CHIEF MEDICAL OFFICER now owns 1,446,494 shares.
Before that, Lowenthal Richard E sold 100,000 shares. ARS Pharmaceuticals Inc shares valued at $1,247,555 were divested by the PRESIDENT AND CEO at a price of $12.48 per share. As a result of the transaction, Lowenthal Richard E now holds 1,446,494 shares, worth roughly $19.28 million.
Raymond James upgraded its ARS Pharmaceuticals Inc [SPRY] rating to a Strong buy from a an Outperform in a research note published on August 13, 2024; the price target was increased to $22 from $18. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who remained covering the stock and in mid August has reiterated a ‘”an Outperform”‘ rating for it. Raymond James began covering SPRY with “an Outperform” recommendation on July 25, 2024. Leerink Partners revised its rating on March 05, 2024. It rated SPRY as “an Outperform” which previously was an “a Market perform”.
Price Performance Review of SPRY
On Friday, ARS Pharmaceuticals Inc [NASDAQ:SPRY] saw its stock fall -1.55% to $13.33. Over the last five days, the stock has gained 22.52%. ARS Pharmaceuticals Inc shares have risen nearly 143.25% since the year began. Nevertheless, the stocks have risen 94.31% over the past one year. While a 52-week high of $13.69 was reached on 08/16/24, a 52-week low of $2.55 was recorded on 01/04/24. SMA at 50 days reached $9.97, while 200 days put it at $7.87.
Levels Of Support And Resistance For SPRY Stock
The 24-hour chart illustrates a support level at 13.16, which if violated will result in even more drops to 12.99. On the upside, there is a resistance level at 13.61. A further resistance level may holdings at 13.89. The Relative Strength Index (RSI) on the 14-day chart is 70.77, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.19, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 8.06%. Stochastics%K at 93.37% indicates the stock is a selling.
How much short interest is there in ARS Pharmaceuticals Inc?
A steep rise in short interest was recorded in ARS Pharmaceuticals Inc stocks on 2024-07-31, growing by 3.04 million shares to a total of 9.93 million shares. Yahoo Finance data shows the prior-month short interest on 2024-06-28 was 6.88 million shares. There was a rise of 30.67%, which implies that there is a positive sentiment for the stock.
